Alexander J. Lepak

2.6k total citations
80 papers, 2.0k citations indexed

About

Alexander J. Lepak is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Alexander J. Lepak has authored 80 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 42 papers in Pharmacology and 33 papers in Epidemiology. Recurrent topics in Alexander J. Lepak's work include Antibiotics Pharmacokinetics and Efficacy (41 papers), Antifungal resistance and susceptibility (30 papers) and Antibiotic Resistance in Bacteria (27 papers). Alexander J. Lepak is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (41 papers), Antifungal resistance and susceptibility (30 papers) and Antibiotic Resistance in Bacteria (27 papers). Alexander J. Lepak collaborates with scholars based in United States, China and United Kingdom. Alexander J. Lepak's co-authors include David R. Andes, Karen Marchillo, Miao Zhao, Jamie VanHecker, Jeniel E. Nett, Daniel J. Diekema, Paul G. Ambrose, Michael A. Pfaller, Brian VanScoy and Lynette Lincoln and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alexander J. Lepak

79 papers receiving 2.0k citations

Peers

Countries citing papers authored by Alexander J. Lepak

Since Specialization

Citations

This map shows the geographic impact of Alexander J. Lepak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander J. Lepak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander J. Lepak more than expected).

Fields of papers citing papers by Alexander J. Lepak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander J. Lepak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander J. Lepak. The network helps show where Alexander J. Lepak may publish in the future.

Co-authorship network of co-authors of Alexander J. Lepak

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander J. Lepak. A scholar is included among the top collaborators of Alexander J. Lepak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander J. Lepak. Alexander J. Lepak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics	Journal of Antimicrobial Chemotherapy	David R. Andes, Roger J. M. Brüggemann et al.	7
2	Understanding clinical implementation coordinators’ experiences in deploying evidence-based interventions	American Journal of Health-System Pharmacy	Vishala Parmasad, Douglas A. Wiegmann et al.	3
3	Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches	Antimicrobial Agents and Chemotherapy	Alexander J. Lepak, Jeffrey Hammel et al.	8
4	Examining the effects of organizational influencers on the implementation of clinical innovations: A qualitative analysis	SHILAP Revista de lepidopterología	Vishala Parmasad, Douglas A. Wiegmann et al.	1
5	Neutropenic Fever–Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 Pandemic	JAMA Network Open	Christos E. Kyriakopoulos, Lucas Schulz et al.	2
6	Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel	Clinical Infectious Diseases	Katarina M. Braun, Gage K. Moreno et al.	38
7	COVID-19 in Health Care Personnel	Mayo Clinic Proceedings	Alexander J. Lepak, Linda Stevens et al.	4
8	FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development	Antimicrobial Agents and Chemotherapy	Edward A. Weinstein, Abhay Joshi et al.	13
9	Implementation of infection control measures to prevent healthcare-associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)	Infection Control and Hospital Epidemiology	Alexander J. Lepak, Daniel Shirley et al.	6
10	Evaluation of a successful fluoroquinolone restriction intervention among high-risk patients: A mixed-methods study	PLoS ONE	Jessica S Tischendorf, Matthew Brunner et al.	7
11	In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistance	Diagnostic Microbiology and Infectious Disease	Thomas M. Gihring, Lucas Schulz et al.	10
12	1383. In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of NOSO-502, a First-in-Class Odilorhabdin Antibiotic, Against E. coli (EC) and K. pneumoniae (KPN) in the Murine Neutropenic Thigh Model	Open Forum Infectious Diseases	Miao Zhao, Alexander J. Lepak et al.	1
13	In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa	Antimicrobial Agents and Chemotherapy	Alexander J. Lepak, Miao Zhao et al.	88
14	Pharmacodynamic Optimization for the Treatment of Invasive Candida auris Infection	Open Forum Infectious Diseases	Alexander J. Lepak, Miao Zhao et al.	2
15	Impact of Low Procalcitonin Results on Antibiotic Administration in Hospitalized Patients at a Tertiary Care Center	Infectious Diseases and Therapy	Meghan B. Brennan, Lucas Schulz et al.	4
16	Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents	Bioorganic & Medicinal Chemistry	Miao Zhao, Alexander J. Lepak et al.	77
17	Top 1% of Inpatients Administered Antimicrobial Agents Comprising 50% of Expenditures: A Descriptive Study and Opportunities for Stewardship Intervention	Infection Control and Hospital Epidemiology	Lucas Schulz, Alexander J. Lepak et al.	8
18	Antifungal PK/PD Considerations in Fungal Pulmonary Infections	Seminars in Respiratory and Critical Care Medicine	Alexander J. Lepak, David R. Andes	17
19	Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting	Critical Care Clinics	Alexander J. Lepak, David R. Andes	43
20	Time Course Global Gene Expression Analysis of an In VivoCandidaBiofilm	The Journal of Infectious Diseases	Jeniel E. Nett, Alexander J. Lepak et al.	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact